Consulting with Major Distributors in the Middle East, South America, and Europe for Tentherma Supply
Expanding Global Portfolio with Next-Generation Lineups, Including Tentriple and Tenlux

Tentech Co., Ltd. (CEO Dong-ok Han, hereinafter "Tentech"), a company specializing in aesthetic medical devices, announced its participation in the world's largest aesthetic plastic surgery conference, "IMCAS World Congress 2026" (hereinafter "IMCAS"), held in Paris, France.

Now in its 28th year, IMCAS is an international event with 402 companies and over 20,000 healthcare professionals from 136 countries, including Europe, South America, the Middle East, Russia, and Asia. During the exhibition, Tentech conducted promotional activities and held a series of meetings with buyers from the Middle East, South America, Europe, and Oceania, discussing sales contracts and partnerships.

At this event, major local distributors handling global brands such as DEKA, Candela, and Alma reportedly highlighted Tentech's technological prowess and proposed partnerships.

Furthermore, a major distributor in the Middle East is considering expanding its supply chain to introduce the MRF Tentherma (10THERMA, exported overseas as XTHERMA). Discussions are also underway with major European countries such as Germany, Spain, Portugal, and Poland, as well as South American companies in Chile, Colombia, and Argentina. These countries are coordinating detailed schedules with the goal of launching Tentech's flagship Tentherma and HIFU device, Tenthera (10THERA), both of which have received CE MDR certification, within the first half of the year.

Furthermore, Kuwait and Australia have confirmed visits to Tentech during KIMES 2026 to introduce the new product, 10LUX. Distributors of aesthetic medical devices from countries such as Turkey and Canada are also continuing discussions regarding Tentech's entire product lineup.

Specialized seminars sharing Tentech's technological capabilities also contributed to these successes. The seminar hall, which was double the size of the previous year, was fully booked. Speakers, including Dr. Gold, presented the clinical evidence for Tensorma. Dr. Joe then demonstrated the procedure through a live demonstration, drawing keen attention from global buyers.

At this exhibition, Tentech showcased not only Tensorma but also its other product lines, including "10TRIPLE" and Tenlux, which recently received domestic medical device certification. Through these demonstrations, Tentech demonstrated its portfolio expansion strategy based on its R&D capabilities.

Tentech CEO Han Dong-ok stated, "At IMCAS 2026, the largest event ever held, we were able to showcase the excellence of Korean medical devices and confirm the growing interest in Tentech in the global market. We will leverage our global distribution network and clinical data to launch an aggressive global marketing strategy to become a leading global company."